Merck Current Deferred Liabilities (Quarterly) Analysis

Merck & Co., Inc. (MRK)

110.45 -0.54 (-0.49%) USD | NYSE | Jan 09, 16:00

110.60 +0.15 (+0.14%) After-Hours: 18:50

View Current Deferred Liabilities (Quarterly) for MRK.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Liabilities (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	--
Gilead Sciences, Inc.	--
Regeneron Pharmaceuticals, Inc.	Upgrade
Cidara Therapeutics, Inc.	--
Moderna, Inc.	Upgrade